I agree that this site is using cookies. You can find further informations here.
X
Velmurugan, Kamalakannan
20  results:
Search for persons X
?
1

Novel approaches to preclinical research and TB vaccine dev..:

Walker, Kenneth Barry ; Guo, Ming ; Guo, Yan...
Tuberculosis.  99 (2016)  - p. S12-S15 , 2016
Link: https://doi.org/10.1016/..
 
?
2

Immunopathogenesis of tuberculosis and novel mechanisms of ..:

Schrager, Lewis K. ; Izzo, Angelo ; Velmurugan, Kamalakannan
Tuberculosis.  99 (2016)  - p. S3-S7 , 2016
Link: https://doi.org/10.1016/..
 
?
3

Nonclinical Development of BCG Replacement Vaccine Candidat..:

Velmurugan, Kamalakannan ; Grode, Leander ; Chang, Rosemary...
Vaccines.  1 (2013)  2 - p. 120-138 , 2013
Link: https://doi.org/10.3390/..
 
?
4

The Type I NADH Dehydrogenase of Mycobacterium tuberculosis..:

Miller, Jessica L. ; Velmurugan, Kamalakannan ; Cowan, Mark J...
PLoS Pathogens.  6 (2010)  4 - p. e1000864 , 2010
Link: https://doi.org/10.1371/..
 
?
5

The non-pathogenic mycobacteria M. smegmatis and M. fortuit..:

Bohsali, Amro ; Abdalla, Hana ; Velmurugan, Kamalakannan.
BMC Microbiology.  10 (2010)  1 - p. , 2010
Link: https://doi.org/10.1186/..
 
?
6

Mycobacterium tuberculosis nuoG Is a Virulence Gene That In..:

Velmurugan, Kamalakannan ; Chen, Bing ; Miller, Jessica L...
PLoS Pathogens.  3 (2007)  7 - p. e110 , 2007
Link: https://doi.org/10.1371/..
 
?
7

Nonclinical Development of BCG Replacement Vaccine Candidat..:

Velmurugan, Kamalakannan ; Grode, Leander ; Chang, Rosemary...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515585/.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
8

The non-pathogenic mycobacteria M. smegmatis and M. fortuit..:

Bohsali Amro ; Abdalla Hana ; Velmurugan Kamalakannan.
http://www.biomedcentral.com/1471-2180/10/237.  , 2010
Link: https://doi.org/10.1186/..
 
?
9

The non-pathogenic mycobacteria M. smegmatisand M. fortuitu..:

Bohsali, Amro ; Abdalla, Hana ; Velmurugan, Kamalakannan.
http://www.biomedcentral.com/1471-2180/10/237.  , 2010
Link: http://www.biomedcentral..
 
?
10

Nonclinical Development of BCG Replacement Vaccine Candidat..:

Kamalakannan Velmurugan ; Leander Grode ; Rosemary Chang...
https://dx.doi.org/10.3390/vaccines1020120.  , 2013
Link: https://doi.org/10.3390/..
 
?
11

Nonclinical Development of BCG Replacement Vaccine Candidat..:

Bernd Eisele ; Martin Gengenbacher ; Reginald Kidd...
http://www.mdpi.com/2076-393X/1/2/120.  , 2013
Link: https://doi.org/10.3390/..
 
?
12

The type I NADH dehydrogenase of Mycobacterium tuberculosis..:

Jessica L Miller ; Kamalakannan Velmurugan ; Mark J Cowan.
http://europepmc.org/articles/PMC2858756?pdf=render.  , 2010
Link: https://doi.org/10.1371/..
 
?
13

Mycobacterium tuberculosis nuoG is a virulence gene that in..:

Kamalakannan Velmurugan ; Bing Chen ; Jessica L Miller...
http://europepmc.org/articles/PMC1924871?pdf=render.  , 2007
Link: https://doi.org/10.1371/..
 
?
14

Monascus pigment production by solid-state fermentation wit..:

Velmurugan, Palanivel ; Hur, Hyun ; Balachandar, Vellingiri...
Journal of Bioscience and Bioengineering.  112 (2011)  6 - p. 590-594 , 2011
Link: https://doi.org/10.1016/..
 
?
15

Removal of zinc by live, dead, and dried biomass of Fusariu..:

Velmurugan, Palanivel ; Shim, Jaehong ; You, Youngnam...
Journal of Hazardous Materials.  182 (2010)  1-3 - p. 317-324 , 2010
Link: https://doi.org/10.1016/..
 
1-15